ROCKVILLE, Md., July 26, 2016 /PRNewswire/ -- Synthetic
Biologics, Inc. (NYSE MKT: SYN), a clinical-stage company focused
on developing therapeutics to protect the microbiome while
targeting pathogen-specific diseases, intends to release its
operational highlights and financial results for the three and six
months ending June 30, 2016, on
Wednesday, August 3, 2016, and to
host a conference call the same day at 4:30
p.m. EDT.
The dial-in
information for the call is as follows:
|
U.S. (toll
free):
|
1-888-347-5280
|
International:
|
+1
412-902-4280
|
Participants are asked to dial in 15 minutes before the start of
the call to register. The call will also be webcast over the
Internet at https://www.webcaster4.com/Webcast/Page/1096/16339. An
archive of the call will be available for approximately 90 days at
the same URL, https://www.webcaster4.com/Webcast/Page/1096/16339,
beginning approximately one hour after the call's conclusion.
About Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (NYSE MKT: SYN) is a clinical stage
company developing therapeutics to protect the gut microbiome while
targeting pathogen-specific diseases. The Company's lead candidates
in Phase 2 development are: (1) SYN-010 which is intended to reduce
the impact of methane producing organisms in the gut microbiome to
treat an underlying cause of irritable bowel syndrome with
constipation (IBS-C), and (2) SYN-004 (ribaxamase) which is
designed to protect the gut microbiome from the effects of certain
commonly used intravenous (IV) beta-lactam antibiotics for the
prevention of C. difficile infection, antibiotic-associated
diarrhea (AAD) and the emergence of antibiotic-resistant organisms.
The Company is also developing preclinical stage monoclonal
antibody therapies for the prevention and treatment of pertussis
and novel discovery stage biotherapeutics for the treatment of
phenylketonuria (PKU). For more information, please visit Synthetic
Biologics' website at www.syntheticbiologics.com.
Logo
- http://photos.prnewswire.com/prnh/20160105/319502LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/synthetic-biologics-to-report-second-quarter-2016-operational-highlights-and-financial-results-on-august-3-2016-300303745.html
SOURCE Synthetic Biologics, Inc.